Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cidara Therapeutics

16.43
-1.3900-7.80%
Post-market: 16.430.00000.00%16:05 EDT
Volume:119.54K
Turnover:1.97M
Market Cap:179.97M
PE:-0.61
High:17.20
Open:17.20
Low:16.10
Close:17.82
Loading ...
Aug 12, 2021

Major Issues Report

8-K - Current report
Jul 20, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 24, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
Apr 06, 2021

Major Issues Report

8-K - Current report
Apr 05, 2021

Major Issues Report

8-K - Current report
Mar 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Major Issues Report

8-K - Current report